Clinical Researcher—January 2021 (Volume 35, Issue 1) THE LEGAL LANDSCAPE Robert King There are dozens of issues that can slow clinical trial negotiations. Among the worst offenders are “risk […]
Clinical Researcher—January 2021 (Volume 35, Issue 1) TRIALS & TECHNOLOGY Jane Z. Reed The drug development process is lengthy, complex, and expensive, which is why it’s important for pharmaceutical […]
Clinical Researcher—January 2021 (Volume 35, Issue 1) OVER THE TRANSOM Gary W. Cramer Nothing stays still for very long in the world of technology and best practices for clinical […]
The COVID-19 pandemic has upended the clinical trial landscape in ways large and small, agreed experts on the final day of the ACRP 2021 virtual conference's January track (January 14). […]
Calling it a “timely conversation,” Eric Pittman, director of the Bioresearch Monitoring Division at the U.S. Food and Drug Administration (FDA), told attendees of the second day of the ACRP […]